ORYZON to Reshape Its Board of Directors at the Upcoming Shareholders’ Meeting
(Madrid:ORY.MC),(Boerse Stuttgart – Freiverkehr: ORN), Aimed at enhancing U.S. outreach, investor relations, corporate dialogue, and business development (BD) capabilities MADRID and CAMBRIDGE, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announces significant changes […]